Background Although antiretroviral therapy (ART) improves survival in persons with
cryptococcal meningitis (CM) and AIDS, ART frequently elicits HIV immune reconstitution …

… prospective cohort study evaluated neurological outcomes on ART after meningitis as a
nested sub-study of the Cryptococcal … Persons presenting with suspected meningitis to Mulago …

… We conducted a prospective cohort study of adult Ugandans with HIV-associated CM from
… , the Adjunctive Sertraline for HIV-Associated Cryptococcal Meningitis trial (ASTRO-CM) and …

… Strokes—seen at a high rate in our cohort—are a complication of cryptococcal meningitis-associated
vasculopathy and are rarely described.16 Strokes in this setting affect the basal …

… Cryptococcal meningitis (CM) is a leading cause of death in individuals infected with human
immunodeficiency virus (HIV). Identifying factors associated with mortality informs strategies …

… cryptococcal meningitis were selected for the study. Diagnosis of cryptococcal meningitis …
made between isolated cryptococcal meningitis and cryptococcal meningitis with additional …

… in this study have not been validated, although the code for cryptococcal meningitis has
been used to describe the epidemiology of disease [17]. A validation study of ICD-9 diagnosis …

… antigenaemia could predict the development of subsequent cryptococcal meningitis within a
year … samples from a Ugandan cohort of patients who subsequently developed cryptococcal …

… , new cryptococcus, cytomegalovirus, and toxoplasma. Cryptococcal meningitis (CM) is one
of … [2], and it is also the most common fungal infection of the central nervous system, which is …

… First, CM is a rare disease and it was difficult to provide a prospective cohort. Hence, the
major limitation of our study was its retrospective design. Second, because most serotypes of …